China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
The White House is clamping down on pharma’s ability to buy new molecules from Chinese biotechs; Sanofi, Merck and others abandon the U.K. after the introduction of a sizeable levy; Novo CEO Maziar Mike Doustdar lays off 9,000 while the company presents new data at EASD; Capsida loses a patient in a gene therapy trial; […]
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More Read More »
